BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche - PubMed (original) (raw)

BMP2, a key to uncover luminal breast cancer origin linked to pollutant effects on epithelial stem cells niche

Marion Chapellier et al. Mol Cell Oncol. 2015.

Abstract

Chronic exposure of epithelial cells to high levels of bone morphogenetic protein 2 (BMP2) has recently been demonstrated to initiate stem cell transformation toward a luminal tumor-like phenotype through a BMP2-BMPR1B-dependent mechanism. Carcinogen-driven deregulation of the stem cell niche could therefore represent a driving force to promote transformation and dictate the ultimate breast tumor subtype.

Keywords: BMP; BMPR1B; bisphenol; breast tumor; carcinogen; epithelial stem cell; niche; pollutant.

PubMed Disclaimer

Figures

Figure 1.

Figure 1.

Proposed mechanism for bone morphogenetic protein (BMP) function to maintain normal equilibrium and how this this equilibrium is disrupted by environmental pollutants. In normal breast, stem cells (SC) reside in a niche composed of adipocytes (Ad), fibroblasts (Fb), and blood vessels (Bv), that provide cytokines such as BMP2 and BMP4 to maintain normal equilibrium and tissue homeostasis. By binding to bone morphogenetic protein receptor 1B (BMPR1B), BMP2 regulates the amplification and differentiation of luminal progenitors (Lu) whereas BMP4 seems to maintain stem cells and regulate the myoepithelial lineage (My). Downstream intracellular pathways involved in these mechanisms remain to be deciphered. Over the course of a lifetime, the tissue is exposed to a number of pollutants affecting the cellular components of the niche and the different mammary cell types. This can lead to an intrinsic genetic instability among stem cells and progenitors but also to altered extrinsic signals from the niche. BMP2 secretion is increased mainly around blood vessels (Bv) by endothelial and recruited platelets (Pt). A local high concentration of BMP2 leads to increased inflammation and IL6 production from the niche and affects differentiation of stem cells and progenitors via activation of intrinsic signaling pathways. This process contributes to the emergence of cells with luminal features such as high levels of forkhead box A1 (FOXA1), GATA binding protein (GATA3), and estrogen-related genes (estrogen receptor 1 ESR1), and high levels of BMPR1B. Disequilibrium of BMP2 levels might also lead to changes in the niche structure such as local microcalcification (Ca), another early step in the emergence of breast luminal tumors.

References

    1. Chapellier M, Bachelard-Cascales E, Schmidt X, Clément F, Treilleux I, Delay E, Jammot A, Ménétrier-Caux C, Pochon G, Besançon R, et al. Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial Transformation by Overamplifying BMPR1B Cell Response. Stem Cell Reports 2015; 4(2):239-54; PMID:25601208; http://dx.doi.org/ 10.1016/j.stemcr.2014.12.007 - DOI - PMC - PubMed
    1. Massague J, Xi Q. TGF-beta control of stem cell differentiation genes. FEBS Lett 2012; 586(14):1953-8; PMID:22710171; http://dx.doi.org/ 10.1016/j.febslet.2012.03.023 - DOI - PMC - PubMed
    1. Bonilla-Claudio M, Wang J, Bai Y, Klysik E, Selever J, Martin JF. Bmp signaling regulates a dose-dependent transcriptional program to control facial skeletal development. Development 2012; 139(4):709-19; PMID:22219353; http://dx.doi.org/ 10.1242/dev.073197 - DOI - PMC - PubMed
    1. Forsman CL, Ng BC, Heinze RK, Kuo C, Sergi C, Gopalakrishnan R, Yee D, Graf D, Schwertfeger KL, Petryk A. BMP-binding protein twisted gastrulation is required in mammary gland epithelium for normal ductal elongation and myoepithelial compartmentalization. Dev Biol 2013; 373(1):95-106; PMID:23103586; http://dx.doi.org/ 10.1016/j.ydbio.2012.10.007 - DOI - PMC - PubMed
    1. Jeanpierre S, Nicolini FE, Kaniewski B, Dumontet C, Rimokh R, Puisieux A, Maguer-Satta V. BMP4 regulation of human megakaryocytic differentiation is involved in thrombopoietin signaling. Blood 2008; 112(8):3154-3163; PMID:18664625; http://dx.doi.org/ 10.1182/blood-2008-03-145326 - DOI - PubMed

LinkOut - more resources